Lotus Pharmaceutical Co., Ltd. (1795.TW)

TWD 260.5

(-1.14%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 32.99 Billion 29.52 Billion 21.22 Billion 19.75 Billion 17.91 Billion 14.85 Billion
Total Current Assets 12.65 Billion 10.66 Billion 8.33 Billion 6.78 Billion 5.47 Billion 3.55 Billion
Cash And Short Term Investments 1.77 Billion 1.98 Billion 1.6 Billion 1.48 Billion 1.12 Billion 1.02 Billion
Cash and Cash Equivalents 1.77 Billion 1.98 Billion 1.6 Billion 1.48 Billion 1.12 Billion 1.02 Billion
Short Term Investments - -10.91 Million - - - -
Net Receivables 6.61 Billion 4.92 Billion 3.4 Billion 2.8 Billion 2.35 Billion 1.21 Billion
Inventory 3.77 Billion 3.32 Billion 3.07 Billion 2.2 Billion 1.32 Billion 1.16 Billion
Other Current Assets 489.37 Million 420.4 Million 247.23 Million 284.61 Million 671.09 Million 161.97 Million
Total Non-Current Assets 20.33 Billion 18.86 Billion 12.88 Billion 12.97 Billion 12.44 Billion 11.29 Billion
Net PPE 3.51 Billion 3.14 Billion 2.64 Billion 2.3 Billion 2.04 Billion 1.81 Billion
Good Will And Intangible Assets 13.03 Billion 12.98 Billion 9.44 Billion 9.72 Billion 8.8 Billion 8.26 Billion
Good Will 5.66 Billion 5.66 Billion 5.58 Billion 5.89 Billion 5.91 Billion 6.08 Billion
Intangible Assets 7.36 Billion 7.31 Billion 3.86 Billion 3.83 Billion 2.89 Billion 2.18 Billion
Long-Term Investments 3.21 Billion 2.16 Billion 301.72 Million 412.84 Million 458.05 Million 9.03 Million
Tax Assets 411.68 Million 390.11 Million 310.81 Million 364.6 Million 378.64 Million 486.72 Million
Other Non Current Assets 164.41 Million 174.42 Million 185.35 Million 161.11 Million 763.09 Million 714.38 Million
Other Assets - - - - - -
Total Liabilities 15.65 Billion 15.65 Billion 10.15 Billion 11 Billion 10.17 Billion 7.17 Billion
Total Current Liabilities 4.52 Billion 5.89 Billion 4.32 Billion 4.88 Billion 2.95 Billion 2.1 Billion
Account Payables 670.79 Million 1.4 Billion 747.54 Million 1.73 Billion 881.54 Million 727.57 Million
Tax Payables 436.55 Million 731.15 Million 280.15 Million 226.61 Million 49.64 Million 76.57 Million
Short Term Debt 1.88 Billion 274.85 Million 1.67 Billion 450.43 Million 1.09 Billion 610 Million
Deferred Revenue 132.85 Million 183.08 Million 1.88 Billion 1.32 Billion 891.97 Million 76.57 Million
Other Current Liabilities 1.83 Billion 4.03 Billion 20.95 Million 1.37 Billion 91.78 Million 689.47 Million
Total Non Current Liabilities 11.13 Billion 9.76 Billion 5.82 Billion 6.12 Billion 7.21 Billion 5.06 Billion
Long-Term Debt 9.51 Billion 8.64 Billion 4.71 Billion 5.02 Billion 3.83 Billion 1.46 Billion
Deferred Revenue Non Current 45.32 Million 65.91 Million 85.95 Million 111.78 Million 104.03 Million 106.58 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 847.76 Million 607.74 Million 726.73 Million 844.31 Million 3.09 Billion 3.3 Billion
Other Liabilities - - - - - -
Total Equity 17.33 Billion 13.86 Billion 11.06 Billion 8.74 Billion 7.74 Billion 7.68 Billion
Stock Holders Equity 17.33 Billion 13.86 Billion 11.06 Billion 8.74 Billion 7.74 Billion 7.22 Billion
Common Stock 2.64 Billion 2.62 Billion 2.62 Billion 2.45 Billion 2.43 Billion 2.38 Billion
Retained Earnings 8.9 Billion 4.82 Billion 1.7 Billion 353.66 Million -652.93 Million -995.13 Million
Accumulated other comprehensive income 503.82 Million 287.55 Million 159.16 Million 659.26 Million 619.33 Million 1.08 Billion
Common Stock Equity 17.33 Billion 13.86 Billion 11.06 Billion 8.74 Billion 7.74 Billion 7.22 Billion
Capital Lease Obligation 182.2 Million 105.81 Million 105.87 Million 117 Million 169.94 Million -
Total Investments 3.21 Billion 2.15 Billion 301.72 Million 412.84 Million 458.05 Million 9.03 Million
Total Debt 11.58 Billion 8.91 Billion 6.38 Billion 5.47 Billion 4.93 Billion 2.07 Billion
Net Debt 9.81 Billion 6.93 Billion 4.78 Billion 3.98 Billion 3.8 Billion 1.04 Billion

Balance Sheet Charts